We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Evotec webinar 18th September

Unlocking the Potential of miRNA-Targeted Therapies


Want to share this FREE webinar with a colleague?

Fill out the form below and we'll send your colleague an invitation to the "Unlocking the Potential of miRNA-Targeted Therapies" event.

Interest in oligonucleotide therapeutics is growing, with several drugs already approved and many more in development, offering a promising avenue for targeted therapies. However, oligonucleotide therapies targeting microRNA (miRNA) are yet to be successful.


In this webinar, our expert speaker will explore the therapeutic potential of miRNA- targeting treatments, outlining cutting-edge research that is identifying new miRNA targets.


He’ll also discuss the latest methodologies in miRNA research, including next-generation sequencing and miRNA inhibition.


Attend this webinar to:
  • Explore a brief history of oligonucleotide therapeutics, from routine failure to routine success
  • Learn why oligonucleotide therapeutics targeting miRNAs have not been successful
  • Discover how nuclear RNA interference offers a new approach to identifying therapeutic target miRNAs
Speaker
A picture of Dr. David Corey
Dr. David Corey
Rusty Kelley Professor of Biomedical Research
UT Southwestern University
Brought to you by

Have a question about our online events and webinars? Get in touch here.
Now Available on Demand!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Want to invite a colleague?

Click the button below to begin inviting a colleague to this Webinar